Detecting early kidney injury due to host–virus interaction response in treatment-naive CHB—a pilot study
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1601678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Puneet Gandhi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Training, Bhopal Memorial Hospital and Research Centre, Bhopal, India. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Acute Kidney Injury, Host Microbial Interactions. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Purpose
Clinical evidence suggests that patients with chronic hepatitis B (CHB) have an increased risk of renal impairment due to inflammation induced by virus–host interaction. We aimed to evaluate and validate a set of protein biomarkers singularly and in combination for the early detection of subclinical kidney injury in patients with CHB naive to antiretroviral therapy.
Methods
This work is part of a prospective cross-sectional study for which 69 HBsAg-positive, treatment-naive patients with CHB with an equal number of age-matched healthy volunteers were considered. At diagnosis, serum creatinine (sCr), urea, alanine transaminase, aspartate transaminase, serum cystatin-C (sCys-C), serum neutrophil gelatinase-associated lipocalin (sNGAL), serum Fetuin-A (sFet-A), urinary interleukin-18 binding protein (uIL-18BP), and urinary kidney injury molecule-1 (uKIM-1) levels were determined.
Results
There was a significant elevation in the concentrations of three proteins in our CHB cohort (sCys-C, sNGAL, and uIL-18BP; p < 0.0001) while sFet-A was down-regulated ( p <0.01) as compared to the control group. A receiver operating characteristic curve analysis revealed an Area under the curve of 0.935 for sCys-C and 0.811 for sNGAL, which improved to 0.984 when all four indicators were combined in a panel to discriminate the onset of renal injury incited by inflammatory response in CHB with 97.1% sensitivity at 91.3% specificity. Additionally, only sCys-C and sNGAL differed significantly among the phases of CHB infection ( p <0.05).
Conclusions
This novel noninvasive diagnostic screen is expedient in detecting inflammation and early kidney injury before a rise in sCr and can aid in predicting renal outcomes in patients with CHB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Training, Bhopal Memorial Hospital and Research Centre, Bhopal, India.
- Department of Gastrointestinal Surgery, Bhopal Memorial Hospital and Research Centre, Bhopal, India.
- Siddhanta Red Cross Superspeciality Hospital, Bhopal, India.
- Department of Nephrology, Bhopal Memorial Hospital and Research Centre, Bhopal, India.
- Department of Nephrology, All India Institute of Medical Science, Bhopal, India.
- Faculty, Bharati Vidyapeeth Medical College, Pune, India.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Gandhi, P., Peter, K., Varshney, S., Atlani, M. K., & Maudar, K. K. (2025). Detecting early kidney injury due to host–virus interaction response in treatment-naive CHB—a pilot study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1601678
Vancouver
Gandhi P, Peter K, Varshney S, Atlani MK, Maudar KK. Detecting early kidney injury due to host–virus interaction response in treatment-naive CHB—a pilot study. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1601678
BibTeX
@article{Gandhi2025,
author = {Gandhi, Puneet and Peter, Kavita and Varshney, Subodh and Atlani, Mahendra Kumar and Maudar, Kewal Krishan},
title = {Detecting early kidney injury due to host–virus interaction response in treatment-naive CHB—a pilot study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1601678}
}
EUVIMED